EUVIMEDEUVIMED entdecken
Multizentrische Studie

Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease

Ho Soo Chun, Minjong Lee, Hye Ah Lee, Sejin Lee, Soyeon Kim, Ye Jun Jung, Chaewon Lee, Hyoeun Kim, Han Ah Lee, Hwi Young Kim, Kwon Yoo, Tae Hun Kim und 2 weitere

Clinical Gastroenterology and Hepatology · 2023-08 · 21 (9) · 2298-2307.e18

DOI: 10.1016/j.cgh.2022.11.031 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-08. Verfasst von Ho Soo Chun und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea; Department of Internal Medicine, Ewha Womans University Me…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Sarcopenia, Cardiovascular Diseases. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Department of Internal Medicine, University of Utah, Ministry of Education, Ministry of Science, ICT and Future Planning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: The impact of the severity of sarcopenic obesity (SO) in nonalcoholic fatty liver disease (NAFLD) on the risk of significant liver fibrosis or cardiovascular disease (CVD) remains unclear. We aimed to identify high-risk subjects with SO for significant liver fibrosis or CVD among subjects with SO and NAFLD. METHODS: This multicenter, retrospective study involved 23,889 subjects with NAFLD who underwent a health screening program (2014-2020). Sarcopenia was defined based on gender-specific sarcopenia index cutoff using multi-frequency bioelectric impedance analysis. High-risk subjects with SO were defined as those with significant liver fibrosis by fibrosis-4 index >2.67 or atherosclerotic CVD risk score >20%. Multivariable logistic regression analysis for identifying high-risk subjects with SO was performed in a cross-sectional cohort with SO, and further validation was performed in a longitudinal cohort. RESULTS: SO prevalence was 5.4% (n = 1297 of 23,889). Older age (unstandardized beta [β] = 3.23; P < .001), male (β = 1.66; P = .027), sarcopenia index (β = -6.25; P = .019), and metabolic syndrome (β = 1.75; P < .001) were significant risk factors for high-risk SO. Based on a high-risk SO screening model, high-risk subjects with SO had significantly higher odds of significant liver fibrosis (training: adjusted odds ratio [aOR], 3.72; validation: aOR, 2.38) or CVD (training: aOR, 5.20; validation: aOR, 3.71) than subjects without SO (all P < .001). In subgroup analyses, the cumulative incidence of significant liver fibrosis or CVD development was significantly higher in high-risk subjects with SO than in low-risk subjects with SO in a longitudinal cohort considering all-cause mortality and liver transplantation as competing risks (sub-distribution hazard ratio, 5.37; P < .001). CONCLUSION: The high-risk screening model may enable the identification of high-risk subjects with SO with NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseSarcopeniaCardiovascular DiseasesHumansMaleRetrospective StudiesCross-Sectional StudiesRisk FactorsLiver CirrhosisObesityRisk Assessment

Stichwörter der Autor:innen

Cardiovascular DiseaseLiver FibrosisNonalcoholic Fatty Liver DiseaseRisk StratificationSarcopenic Obesity

Autor:innen und Institutionen

  • Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea; Department of Internal Medicine, Ewha Womans University Medical Center, Seoul, Korea.
  • Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea; Department of Internal Medicine, Ewha Womans University Medical Center, Seoul, Korea. Electronic address: minjonglee2@naver.com.
  • Clinical Trial Center, Ewha Womans University Seoul Hospital, Seoul, Korea.
  • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Health Promotion, Health Promotion Center, Severance Hospital, Yonsei University Health System, Seoul, Korea.
  • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea; Yonsei Liver Center, Severance Hospital, Seoul, Korea.

Förderung

  • Department of Internal Medicine, University of Utah
  • Ministry of Education
  • Ministry of Science, ICT and Future Planning
  • National Research Foundation of Korea
  • Hallym University Medical Center

Zitieren

APA

Chun, H. S., Lee, M., Lee, H. A., Lee, S., Kim, S., Jung, Y. J., Lee, C., Kim, H., Lee, H. A., Kim, H. Y., Yoo, K., Kim, T. H., Ahn, S. H., & Kim, S. U. (2023). Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology, 21(9), 2298-2307.e18. https://doi.org/10.1016/j.cgh.2022.11.031

Vancouver

Chun HS, Lee M, Lee HA, Lee S, Kim S, Jung YJ, et al. Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology. 2023;21(9):2298-2307.e18. doi:10.1016/j.cgh.2022.11.031

BibTeX
@article{Chun2023,
  author = {Chun, Ho Soo and Lee, Minjong and Lee, Hye Ah and Lee, Sejin and Kim, Soyeon and Jung, Ye Jun and Lee, Chaewon and Kim, Hyoeun and Lee, Han Ah and Kim, Hwi Young and Yoo, Kwon and Kim, Tae Hun and Ahn, Sang Hoon and Kim, Seung Up},
  title = {Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2023},
  volume = {21},
  number = {9},
  pages = {2298--2307.e18},
  doi = {10.1016/j.cgh.2022.11.031}
}
Kostenlos starten →